Clarity, Cardinal Health Sign Agreement for Targeted Copper Theranostics
Clarity Pharmaceuticals announced that Cardinal Health...
PREDICT Study Demonstrates 40 Percent Change in Radiation Therapy Treatment for DCIS Patients
Prelude Corporation (PreludeDx) will be presenting new...
MTTI, Evergreen Partner to Manufacture Radiopharmaceuticals
Molecular Targeting Technologies, Inc. (MTTI) and...
